Want to see AUNA full AI Analyst Report?
Top Page
Auna S.A. Class A
(NYSE:AUNA)
Select Model
Select Model
Rating:56Neutral
Price Target:
$5.50
▲(7.63% Upside)
Action:Reiterated
Date:08/29/26
The score is driven primarily by moderate financial quality: strong revenue growth and robust recent free cash flow are tempered by near-breakeven net income and still-elevated leverage. Technicals are neutral with mild momentum improvement, while valuation is pressured by negative earnings and no stated dividend yield. Earnings call guidance and cash-flow-driven deleveraging plans are supportive, but margin pressure and unresolved Peru billing reconciliations add meaningful near-term risk.
Positive Factors
Sustained Revenue Growth
Consistent top-line expansion across Mexico, Peru and Colombia, supported by volume growth and a higher mix of complex care, indicates durable demand and provides a foundation for scaling the integrated healthcare platform.
Negative Factors
Persistent Margin Pressure
Operating costs are rising faster than profit in several markets, limiting the benefit of revenue growth. Talent investments, medical costs and statutory pressures could keep margins below historical potential while the platform scales.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Consistent top-line expansion across Mexico, Peru and Colombia, supported by volume growth and a higher mix of complex care, indicates durable demand and provides a foundation for scaling the integrated healthcare platform.
Read all positive factors
Auna S.A. Class A (AUNA) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$383.39M
Dividend YieldN/A
Average Volume (3M)108.88K
Price to Earnings (P/E)―
Beta (1Y)0.46
Revenue Growth16.82%
EPS Growth-93.67%
CountryUS
Employees15,254
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.97
Shares Outstanding30,095,388
10 Day Avg. Volume114,076
30 Day Avg. Volume108,877
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.31
Price to Sales (P/S)0.11
P/FCF Ratio3.08
Enterprise Value/Market Cap3.62
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit0.81
Enterprise Value/Ebitda1.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.65
Revenue Forecast (FY)$4.90B
Auna S.A. Class A Business Overview & Revenue Model
Company Description
Auna S.A. operates as a healthcare services provider, overseeing a network of hospitals and clinics across Mexico, Peru, and Colombia. The company also offers prepaid medical programs in Peru, alongside dental and vision insurance plans for client...
How the Company Makes Money
Auna generates revenue primarily by delivering healthcare services and, where applicable, administering health coverage products. Key revenue streams typically include: (1) patient-care revenue from medical services delivered at its clinics and ho...
Auna S.A. Class A Earnings Call Summary
Earnings Call Date:Aug 18, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 25, 2026
Earnings Call Sentiment Neutral
The call presented balanced results: strong top-line growth, substantially improved cash generation and clear operational momentum (notably in Mexico, Peru membership expansion and Colombia's payer diversification) were offset by material near-term margin pressures. Adjusted EBITDA declined (consolidated -9% FX-neutral) due to investments in talent, statutory cost pressures and billing reconciliations in Peru. Management reaffirmed revenue guidance (~12% FX-neutral) and expects sequential EBITDA improvement and further leverage reduction, but open prior-period reconciliations and cost pressures create near-term uncertainty.Positive Updates
Consolidated Revenue Growth
Consolidated revenue increased 9% year-over-year (FX-neutral), driven by volume growth and a higher mix of high-complexity services across Mexico, Peru and Colombia.
Negative Updates
Consolidated Adjusted EBITDA Decline
Consolidated adjusted EBITDA decreased 9% year-over-year on an FX-neutral basis, reflecting margin pressures across markets, investments in talent and billing-related impacts in Peru.
Read all updates
Q2-2026 Updates
Positive
Negative
Consolidated Revenue Growth
Consolidated revenue increased 9% year-over-year (FX-neutral), driven by volume growth and a higher mix of high-complexity services across Mexico, Peru and Colombia.
Read all positive updates
Company Guidance
Management reaffirmed full‑year 2026 guidance for approximately 12% FX‑neutral revenue growth and expects adjusted EBITDA to grow toward the low end of its 10–14% guidance range (excluding the impact of Peru’s accepted prior‑year billing penalties); they anticipate sequential EBITDA improvement in H2 driven by Mexico’s volume recovery, contractual price increases and stabilization of risk‑sharing and new B2B contracts, and to continue reducing leverage (which was 3.6x in Q2) toward the ~3.0x medium‑term target (management has cited <3x net debt/EBITDA); strong cash generation—cash up 43% vs. year‑end 2025 and free cash flow up 181% YoY—underpins the expectation that leverage will decline and free cash flow will continue to exceed original expectations.Auna S.A. Class A Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
46
Neutral
Cash Flow
67
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.65B | 4.39B | 4.39B | 3.88B | 2.45B | 1.92B |
| Gross Profit | 1.72B | 1.66B | 1.73B | 1.44B | 879.70M | 686.93M |
| EBITDA | 709.69M | 856.65M | 887.03M | 647.30M | 299.14M | 170.15M |
| Net Income | 15.37M | 97.61M | 110.27M | -253.92M | -85.61M | -26.47M |
Balance Sheet | ||||||
| Total Assets | 7.78B | 7.30B | 7.08B | 7.69B | 6.59B | 2.82B |
| Cash, Cash Equivalents and Short-Term Investments | 480.46M | 365.65M | 335.97M | 334.26M | 208.69M | 138.77M |
| Total Debt | 3.72B | 3.66B | 3.77B | 3.92B | 3.51B | 1.49B |
| Total Liabilities | 5.73B | 5.53B | 5.46B | 5.91B | 5.04B | 2.28B |
| Stockholders Equity | 1.86B | 1.60B | 1.48B | 1.47B | 1.06B | 495.82M |
Cash Flow | ||||||
| Free Cash Flow | 503.63M | 161.76M | 577.64M | 417.25M | 10.67M | -106.03M |
| Operating Cash Flow | 595.72M | 242.83M | 668.50M | 582.41M | 162.64M | 183.34M |
| Investing Cash Flow | -18.88M | -78.83M | -236.82M | -173.15M | -3.21B | -291.99M |
| Financing Cash Flow | -288.94M | -74.31M | -418.12M | -370.00M | 3.13B | -102.13M |
Auna S.A. Class A Technical Analysis
Positive
5.11
Price Trends
5.19
Negative
5.05
Positive
5.10
Positive
Market Momentum
-0.02
Negative
53.99
Neutral
80.62
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AUNA, the sentiment is Positive. The current price of 5.11 is above the 20-day moving average (MA) of 5.11, below the 50-day MA of 5.19, and above the 200-day MA of 5.10, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 53.99 is Neutral, neither overbought nor oversold. The STOCH value of 80.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AUNA.
Auna S.A. Class A Risk Analysis
Auna S.A. Class A disclosed 57 risk factors in its most recent earnings report. Auna S.A. Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Auna S.A. Class A Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | $383.39M | -18.39 | 0.90% | ― | 16.82% | -93.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | $1.74B | -5.84 | -26.06% | ― | 49.37% | -171.65% | |
44 Neutral | $117.52M | -8.98 | -12.52% | 4.45% | -8.71% | 26.89% | |
42 Neutral | $411.75M | -1.29 | 20.91% | 0.70% | -5.25% | ― |
* Healthcare Sector Average
AUNA
Auna S.A. Class A
5.18
-1.38
-21.04%
SNDA
Sonida Senior Living
36.15
10.02
38.35%
CYH
Community Health
2.92
<0.01
0.34%
AIRS
Airsculpt Technologies
1.63
-8.07
-83.20%
Auna S.A. Class A Corporate Events
Auna Posts Strong Q2 2026 Revenue and Cash Flow as It Expands High-Complexity Care Network
Aug 18, 2026
For the second quarter ended June 30, 2026, Auna reported continued top-line momentum, with revenue rising 9% on a FX-neutral basis and 13% year over year to S/1,238 million, while adjusted EBITDA fell 9% FXN amid margin pressure in Mexico and Col...
Auna Shareholders Approve 2025 Accounts as Board Streamlines to Seven Members
Jul 7, 2026
On June 30, 2026, Auna S.A. held its annual general meeting of shareholders in Luxembourg, during which investors approved all proposals related to 2025 governance and financial reporting. These included confirmation of share awards to independent...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.